Syndax Pharmaceuticals, Inc.
USD22.64
+0.35 (+1.57%)
CEO
Michael A. Metzger
IPO Date
2016-03-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$22.37
Prev. Close
$22.29
Day Low
$22.10
Day High
$22.72
52W Low
$9.42
52W High
$25.59
Market Cap
$2.01B
Volume
1.19M
| 32,375 |
| $24.24 |
| 9 Jul 2026 | Metzger Michael A | director, officer: Chief Executive Officer | M-Exempt | Acquired | 32,375 | $6.38 |
| 12 Jun 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | M-Exempt | Acquired | 22,515 | $13.82 |
| 12 Jun 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | S-Sale | Disposed | 34,280 | $18.00 |
| 12 Jun 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | M-Exempt | Acquired | 31,235 | $13.82 |
| 12 Jun 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | S-Sale | Disposed | 31,235 | $18.14 |
| 12 Jun 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | M-Exempt | Acquired | 31,235 | $13.82 |
| 2 Jun 2026 | Goldan Keith A. | Chief Financial Officer | S-Sale | Disposed | 1,177 | $18.99 |
| 2 Jun 2026 | Metzger Michael A | director, officer: Chief Executive Officer | S-Sale | Disposed | 6,847 | $18.99 |